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ABSTRACT
Objectives Evidence of surgical transmission of sporadic
CreutzfeldteJakob disease (sCJD) remains debatable in
part due to misclassiﬁcation of exposure levels. In
a registry-based caseecontrol study, the authors applied
a risk-based classiﬁcation of surgical interventions to
determine the association between a history of surgery
and sCJD.
Design Caseecontrol study, allowing for detailed
analysis according to time since exposure.
Setting National populations of Denmark and Sweden.
Participants From national registries of Denmark and
Sweden, the authors included 167 deﬁnite and probable
sCJD cases with onset during the period 1987e2003,
835 age-, sex- and residence-matched controls and
2224 unmatched. Surgical procedures were categorised
by anatomical structure and presumed risk of
transmission level. The authors used logistic regression
to determine the odds ratio (OR) for sCJD by surgical
interventions in speciﬁed time-windows before disease-
onset.
Results From comparisons with matched controls,
procedures involving retina and optic nerve were
associated with an increased risk at a latency of $1 year
OR (95% CI) 5.53 (1.08 to 28.0). At latencies of 10 to
19 years, interventions on peripheral nerves 4.41 (1.17
to 16.6) and skeletal muscle 1.58 (1.01 to 2.48) were
directly associated. Interventions on blood vessels 4.54
(1.01 to 20.0), peritoneum 2.38 (1.14 to 4.96) and
skeletal muscle 2.04 (1.06 to 3.92), interventions
conducted by vaginal approach 2.26 (1.14 to 4.47) and
a pooled category of lower-risk procedures 2.81 (1.62 to
4.88) had an increased risk after $20 years. Similar
results were found when comparing with unmatched
controls.
Interpretation This observation is in concordance with
animal models of prion neuroinvasion and is likely to
represent a causal relation of surgery with a non-
negligible proportion of sCJD cases.
INTRODUCTION
CreutzfeldteJakob disease (CJD) is a rare, fatal
neurodegenerative disease characterised by deposi-
tion of a pathological isoform of the normal cellular
prion protein (PrP
C). CJD exists in various forms,
namely, genetic, caused by mutations in the gene
encoding PrP
C, acquired (variant and iatrogenic)
and sporadic. Most cases are classiﬁed as sporadic
(sCJD). Twelve caseecontrol studies
1e12 and one
meta-analysis
13 have examinedsurgical transmission
of sCJD. The outcomes have been partly diverging
due to methodological constraints, including
problems in selection of control subjects and in
particular exposure assessment.
91 4Most studies
have relied on surrogate informants and medical
records for surgical histories, inevitably prone to
recall- and selection-bias. A recent register-based
caseecontrol study,
9 which by design had a less
biased assessment of surgical exposures,
15 corrob-
orated that a proportion of sCJD may be trans-
mitted by surgery following long incubation
periods (20 years or more). However, a limitation
shared by all the above-mentioned studies could
be misclassiﬁcation bias induced by the use of
standard categories of surgical procedures (SP).
Caseecontrol studies focussing on surgical
transmission of sCJD have been conducted using
convenient anatomical references for classiﬁcation
of surgical interventions
1e8 10e12 or national body-
system classiﬁcations of SP.
9 However, such a stan-
dard classiﬁcation of surgical exposures may lead to
misclassiﬁcation. For example, in many ophthalmic
and neurosurgical procedures, surgical instruments
are not likely to encounter potentially high-risk
infective tissue.
16 In a Swedish dataset, only 27% of
ophthalmological SP were included in a risk cate-
gory in which contact with retina and optic nerve
was explicit or likely.
17 As neither infectivity, nor
cellular prion-protein expression patterns, nor the
routes of experimentally transmitted infections ﬁt
broad anatomic SP classiﬁcations or groups used in
prior research, we created a risk-based classiﬁcation
system for surgical exposures.
17 Sensitivity analysis
corroborated that caseecontrol studies in this ﬁeld
may have been subject to misclassiﬁcation bias due
to the use of SP classiﬁcations that were insufﬁ-
ciently speciﬁc or sensitive to distinguish between
low-risk and high-risk interventions for sCJD
transmission.
17
The aim of the present study was to apply the
risk-based classiﬁcation system
17 to determine the
association between surgery and sCJD and thereby
quantify effects potentially masked in prior casee
control studies.
1e12
METHODS
Study design and selection of cases and controls
The study was designed
9 as a caseecontrol study
including 167 probable or deﬁnite sCJD cases
fulﬁlling established EUROCJD diagnostic
criteria,
18 with clinical onset during the period
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Research paper1987e2003, and resident in Denmark or Sweden. Two sets of
randomly selected population controls were included, that is,
835 matched (MC, 5:1 by gender, year, month of birth, and
municipality of residence at death of the corresponding case)
and 2224 unmatched controls (UMC, sampled from the annual,
resident, national study populations aged 40 years and over). For
latency analysis purposes, three time windows (TWs) were
adopted as described.
9 These were based on two operational
dates, of death and of clinical onset for cases, and corresponding
index dates, denoted index dates 1 and 2 (ID-1 and ID-2), for
controls (ﬁgure 1).
9 Relevant parameters for our design of TWs
1,2 and 3 were onset of surgical procedure registration at
hospital discharges in the early 1970s, reported length of latency
time in iatrogenic CJD due to dura mater grafts, uncertainties in
symptoms onset in sCJD and the study size.
Exposure ascertainment
The surgical history was obtained from national registers, and
assigned, blind to subjects’ case or control status, to one of the
three TWs, and, where required to all three pooled TWs covering
registered hospital stay up to 1 year before clinical onset or ID-2.
For cases and controls, data on past hospital discharges
(diagnoses, SP codes, and dates of admission and discharge) were
obtained from the National Hospital Discharge Registers in
Sweden and Denmark. Personal identiﬁers and case-status indi-
cation were removed before analysing the data with respect to
exposure to SP. Reported SP codes were identiﬁed and cate-
gorised according to Swedish, Danish and Nordic (NOMESCO-
NCSP) SP classiﬁcations.
19e21 Codes describing procedures that
were not properly surgical, for example, delivery, and non-
speciﬁc codes, for example ‘investigative procedures connected
with surgery’, were omitted. The 5990 remaining SP were
categorised into two major groups, namely: ‘main surgical
procedures’, and ‘subsidiary procedures’, a heterogeneous cate-
gory that included minor surgery (punctures, needle aspiration
or biopsy, superﬁcial incision), other non-surgical, potentially
invasive procedures, such as transluminal endoscopies (with or
without biopsy) and, in a few instances in Denmark, blood
transfusion. The selected surgical experience of cases and
controls corresponded to 1445 distinct SP codes and 5990 SP
associated with 3876 registered discharges during TWs 1e3, that
Figure 1 Schematic illustration of the
study design and methodological
procedure for life-time-interval deﬁnition
of the registered surgical history of
cases and controls. Time windows
included in the present study were
those covering surgical history >1 year
prior to clinical onset of cases or index-
date-2 of controls, namely, windows 1,
2 and 3. Modiﬁed from Mahillo-
Fernandez et al,
9 where details of
individuals’ life-time references are
given.
a
b
Figure 2 (A) Example of individual categories of exposure by tissue/
structure under study when focusing on retina and optic nerve, at
a speciﬁc window, for three different individuals. (B) Surgical procedure
risk categories after reclassiﬁcation, and corresponding individual
categories of exposure to surgery.
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Research paperis, dating one or more years before the operational disease onset
or ID-2 used in the reported study.
9
SP reclassiﬁcation by risk level
A total of 1445 unrepeated SP codes were decoded, and their
5990 discharge dates were reclassiﬁed blindly to individual
outcomes according to the reported method.
17 The following
two attributes were assigned to each SP: (a) probable use of non-
disposable instruments involved; and (b) list of up to four (of the
24 reported) tissue types or anatomical structures with the
highest assigned risk level most likely contacted by such
instruments.
22 In total, 4813 repeated or not SP codes with
different discharge dates were reclassiﬁed into six putative
categories of CJD-acquisition risk level
16: high risk; diluted high
risk; lower risk; diluted lower risk; lowest risk; no risk (when
deemed to have been conducted with disposable instruments).
Furthermore, 1177 SP were not reclassiﬁed, including 865
transluminal endoscopies and 198 minor surgical procedures and
blood transfusions. Endoscopies were not reclassiﬁed because
early registration periods did not discriminate between proce-
dures that were and those that were not associated with inva-
sive procedures such as biopsies.
SP reclassiﬁcation by tissue/structure
Surgical exposure was deﬁned as tissue/structure-speciﬁcb y
possible contact of non-disposable instruments with up to four
assigned tissues/structures.
17 The above-mentioned 4813 SP
generated up to four of 24 binary categorical variables for 24
different types of tissue or anatomical structure.
22
Individual exposure assignment by potential entry site
An individual was assigned to one out of three mutually
exclusive exposure categories per window (see ﬁgure 2A for
examples), namely: exposed to tissue/structure under study;
exposed to other tissues/structures; and unexposed.
< An individual was assigned as exposed to a speciﬁc tissue/
structure under study when at least one discharge associated
with a SP involving such tissue/structure was found at a date
within the limits of a TW.
< An individual was deemed as exposed to a tissue/structure
other than that under study, during any given TW, when at
least one discharge was associated with a tissue/structure
other than that under study. Persons solely exposed to no risk
and not-reclassiﬁed SP were included here.
< Finally, unexposed individuals were deﬁned as those who had
never been discharged or undergone a discharge associated
with any ‘reclassiﬁed’ or ‘not-reclassiﬁed’ SP during the TW
under study.
Individual exposure assignment by putative risk level
Individual levels of exposure were collapsed to ﬁve categories,
ﬁgure 2B. These were: (1) high risk; (2) lower risk; (3) lowest
risk; (4) no risk or not-reclassiﬁed procedures; and (5) unexposed.
The hypothetical risk level of surgical exposure assigned to
a given individual during a speciﬁc TW was the highest SP risk
Figure 3 Percentage distributions of
5990 selected surgical procedure codes
associated with surgical discharges
during TWs 1e3, either classiﬁed by
body-system or reclassiﬁed by
hypothetical transmission risk level
(n¼5990) or contacted tissue/structure
(n¼4813). Three surgical procedure
categories yielding Zero values
(trigeminal ganglia, olfactory mucosa
and cerebrospinal ﬂuid), are not
represented. Added percentages by
tissue or anatomic structure exceed
100%.
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Research paperlevel found to be associated with the hospital discharges regis-
tered during that TW. As done in the preceding report, an indi-
vidual was classiﬁed as exposed to a speciﬁc risk category of
surgery in a speciﬁc TW when at least one discharge associated
with at least one code of such surgery had taken place at a date
within the limits of the individually designated TW. Multiple
exposures to a speciﬁc category were determined by the number
of surgical discharges with one or more SP codes reclassiﬁed in
that same category.
Data analysis
We determined the risk of sCJD by presumed risk level and by
contacted tissue/structure. Statistical methods with regard to
design of variables, choice of reference groups, latency intervals,
multivariate models and procedures for calculation of 95% CIs
(CI) replicate those used in the preceding analysis.
9 Conditional
logistic regression was used for comparisons with MCs, and
logistic regression with adjustment for age, sex and country of
residence at ID-1, for comparisons with UMCs. Exposures
during single TWs, 1, 2 and 3, and one combined TW, 1e3, that
is, predating onset/ID-2 by $1 year, were included in main and
complementary analyses. When an association was based on
a meaningful number of exposed cases, we explored the presence
of a doseeresponse effect quantifying the linear increase in
OR for the number of surgical discharges. We assessed
potential confounding by associated tissue/structure types in
tissue/structure-speciﬁc models, by including, as independent
variables, the tissue/structure present in at least 25% of the
discharges associated with the repeated or unrepeated tissue/
structure-speciﬁc SP under study. Since only comparisons
related to single one-at-a-time hypotheses were planned, we
followed Rothman, Greenland and Last, recommendations to
refrain from use of conventional procedures for widening the
conﬁdence intervals.
23
The study was formally notiﬁed to the Danish Data Protection
Agency (record No 2003-41-3104) and approved by the Karolinska
Institute Ethics Committee (South; report No 452/02).
RESULTS
Figure 3 shows, separately for cases and controls, the results of
the reclassiﬁcation of the 5990 selected SP. Surgery on brain,
retina, spinal cord and pituitary gland or dura mater accounted
for approximately 2% of reclassiﬁed procedures.
In the analyses of risk factors for sCJD, high-risk surgery
among cases was almost absent in all TWs, which made
statistical inference less meaningful for these SPs (table 1).
However, lower-risk surgery carried out more than 20 years
before disease-onset or ID-2 was associated with an increased
risk of sCJD (OR for MCs (ORMC) 2.81 and an OR for UMCs
(ORUMC) of 2.54). Furthermore, for lower-risk procedures there
was a doseeresponse relation with a linear increase by discharge
(ORMC 1.34 and ORUMC 1.33). In addition, point estimates of
the OR increased by latency period for lower-risk surgery, and
those for latencies 10 years or longer decreased moving from
high risk through lower risk to lowest risk.
For surgery classiﬁed by the tissue/structure involved, results
from comparisons with matched and unmatched control groups
were fairly similar. Findings for surgery conducted at any time
throughout the entire study period, TWs 1e3, were negative
(table 2), except when instruments contacted retina and optic
nerve being in such case associated with an increased risk of
sCJD ORMC (95% CI) 5.53 (1.08 to 28.0) (based on three exposed
cases and compared with matched controls only). However, 16
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Research paperof the 23 remaining comparisons yielded statistically non-
signiﬁcant OR point values above the unit. No signiﬁcant
differences were found at 1e9 years before onset (data not
shown). For surgery conducted 10e19 years before onset, TW-2
(table 3), point estimates generally exceeded 1, being statistically
signiﬁcantly higher in both comparisons those for surgery in
contact with peripheral nerves and, when compared with MCs
only, those for surgery on skeletal muscle. Several signiﬁcant
differences were found at TW-1, $20 years (table 4), for several
categories, including surgery involving blood vessels, perito-
neum, skeletal muscle and the group of other tissues.
When complementary subgroup analyses by alternative TWs
were conducted, we observed a statistically signiﬁcant excess
risk for lower-risk surgery performed at least 15 years before
onset in both comparisons, and for putatively high-risk surgery
performed 5e14 years before onset using UMCs (table 5). Posi-
tive ﬁndings similar to those yielded by the core analysis were
detected for strata by country, sex, alternative study period and
age at CJD onset, or for deﬁnite cases, during both TW-1 and
TW-2 (data not shown).
We went on to explore which speciﬁc operations among cases
might have contributed to the excess risk. The highest risk,
observed for surgery on the retina during the combined TWs
1e3, was based on two surgical discharges after retinal detach-
ment and one involving electrocoagulation of choroidea and
retina dating back 9, 12 and 13 years before clinical onset.
Surgery during TW-1 with a lower but signiﬁcant risk excess
included SP on: blood vessels (n¼6, corresponding in all cases to
veins); peritoneum (n¼15, with four and 11 of them being
gynaecological and gastrointestinal, respectively); skeletal
muscle (n¼23, with seven and ﬁve of the SP codes being
gynaecological/obstetric- and bone/orthopaedic-related, respec-
tively); and ‘other tissues’ (n¼28, with the majority of these
being gynaecological SP with vaginal approach, for example,
uterus curettage, n¼12, and interventions on cervix n¼9).
Surgery during TW-2 on peripheral nerves among cases (n¼4)
Table 2 Associations for surgery by tissue/structure contacted 1 or more years before onset or ID-2
Unexposed* Tissue/structure under study Other surgeryy
Tissue/structure Subject n (%) n (%) OR (95% CI) n (%)
Retina, optic nerve Case 72 (43.1) 3 (1.8) 92 (55.1)
MC 399 (47.8) 3 (0.4) 5.53 (1.10 to 27.79) 433 (51.9)
UMC 1056 (47.5) 14 (0.6) 2.96 (0.66 to 9.62) 1154 (51.9)
Spinal ganglia Case 72 (43.1) 1 (0.6) 94 (56.3)
MC 399 (47.8) 3 (0.4) 1.77 (0.18 to 17.04) 433 (51.9)
UMC 1056 (47.5) 8 (0.4) 1.66 (0.09 to 9.74) 1160 (52.2)
Dura mater Case 72 (43.1) 1 (0.6) 94 (56.3)
MC 399 (47.8) 10 (1.2) 0.53 (0.07 to 4.27) 426 (51.0)
UMC 1056 (47.5) 11 (0.5) 1.19 (0.06 to 6.49) 1157 (52.0)
Peripheral nerves Case 72 (43.1) 5 (3.0) 90 (53.9)
MC 399 (47.8) 13 (1.6) 2.10 (0.74 to 6.00) 423 (50.7)
UMC 1056 (47.5) 39 (1.8) 1.76 (0.58 to 4.31) 1129 (50.8)
Lymph nodes Case 72 (43.1) 9 (5.4) 86 (51.5)
MC 399 (47.8) 52 (6.2) 0.97 (0.46 to 2.07) 384 (46.0)
UMC 1056 (47.5) 122 (5.5) 0.92 (0.41 to 1.81) 1046 (47.0)
Tonsil Case 72 (43.1) 1 (0.6) 94 (56.3)
MC 399 (47.8) 8 (1.0) 0.69 (0.09 to 5.60) 428 (51.3)
UMC 1056 (47.5) 21 (0.9) 0.99 (0.05 to 4.97) 1147 (51.6)
Kidney Case 72 (43.1) 1 (0.6) 94 (56.3)
MC 399 (47.8) 6 (0.7) 0.92 (0.11 to 7.72) 430 (51.5)
UMC 1056 (47.5) 5 (0.2) 2.58 (0.13 to 16.92) 1163 (52.3)
Blood vessels Case 72 (43.1) 15 (9.0) 80 (47.9)
MC 399 (47.8) 56 (6.7) 1.51 (0.80-2.85) 380 (45.5)
UMC 1056 (47.5) 109 (4.9) 1.66 (0.88 to 2.97) 1059 (47.6)
Anterior olphtalmic Case 72 (43.1) 7 (4.2) 88 (52.7)
MC 399 (47.8) 19 (2.3) 2.10 (0.83 to 5.32) 417 (49.9)
UMC 1056 (47.5) 52 (2.3) 1.60 (0.63 to 3.55) 1116 (50.2)
Skeletal muscle Case 72 (43.1) 63 (37.7) 32 (19.2)
MC 399 (47.8) 257 (30.8) 1.38 (0.94 to 2.02) 179 (21.4)
UMC 1056 (47.5) 714 (32.1) 1.33 (0.92 to 1.91) 454 (20.4)
Peritoneum Case 72 (43.1) 34 (20.4) 61 (36.5)
MC 399 (47.8) 136 (16.3) 1.44 (0.89 to 2.33) 300 (35.9)
UMC 1056 (47.5) 389 (17.5) 1.32 (0.85 to 2.04) 779 (35.0)
Subcutaneous Case 72 (43.1) 6 (3.6) 89 (53.3)
MC 399 (47.8) 26 (3.1) 1.28 (0.51 to 3.24) 410 (49.1)
UMC 1056 (47.5) 88 (4.0) 0.89 (0.33 to 1.96) 1080 (48.6)
Other tissues Case 72 (43.1) 43 (25.7) 52 (31.1)
MC 399 (47.8) 198 (23.7) 1.22 (0.79 to 1.88) 238 (28.5)
UMC 1056 (47.5) 533 (24.0) 1.17 (0.78 to 1.74) 635 (28.6)
OR for comparisons with unmatched controls (UMC) was adjusted by age, sex and country.
*Reference category. No registered surgery.
yReclassiﬁed procedures involving tissues/structures different from that on study only.
MC, matched controls.
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acoustic nerve neurinoma excision and one pyloroplasty
+vagotomy, and 10 of 33 SP under the ‘skeletal muscle’ heading
were gynaecological procedures.
DISCUSSION
The key features of the present study design enabled us to
address novel aspects of the potential of surgical transmission of
CJD.
9 The additional introduction of an aetiological classiﬁca-
tion, that is unmasking associations hidden by the body-system
approach,
17 24 revealed a number of statistically signiﬁcant
associations, associations of higher magnitude and new effects
with a particular pattern at 10e19 years’ latency. Limitations,
which in part are discussed elsewhere,
9 comprise: the low
statistical power for some latencies and exposure categories;
missing information on interventions undergone prior to regis-
tration or as outpatients; and lack of control of potential
confounders such as blood transfusion, overlooked dura mater
implants or hospital hygiene level.
The new SP classiﬁcation system was built in a tissue/struc-
ture classiﬁcation reported in 2005
22 combining features of the
ﬁrst WHO Classiﬁcation on Tissue infectivity
25 and of experi-
mental efﬁciency of prion disease transmission to animals when
using different routes of inocula administration.
26e29 The plau-
sibility of the risk excess of surgery of retina and peripheral
nerves seen here might be supported by studies in experimental
scrapie (Sc). PrP
Sc injected into the eye travelling via deﬁned
neuroanatomical connections has been demonstrated to be able
to reach larger brain regions.
30 31 In hamsters, PrP
Sc spreads
along the vagus nerve to the medulla, pons, midbrain, cere-
bellum and thalamus via neuroanatomical pathways.
32 The
increasing risk found for SP involving veins, peritoneal cavity
and lymph nodes at longer latencies ﬁts proposals on prion
neuroinvasion and transport, suggesting that prions ﬁrst
replicate and accumulate in the lymphoreticular system (LRS)
(see Aguzzi and Calella
33 for a recent review). In addition, it
would appear that risk excess and latency are inversely corre-
lated: for surgery of retina, OR 5.53, at mean 11 years; for
surgery of peripheral nerves, OR 4.41, at 10e19 years; and for
lower-risk SP OR 2.4, at $20 years. In summary, our ﬁndings
might be consistent with proposed biological mechanisms
potentially underlying the rapid access to the CNS by direct
contact,
34 prion uptake through the skin, neuroinvasion from
the spleen and spread of prions along peripheral and CNS
pathways.
33 35
Compared with other studies, the main contribution of
the new methodology may be credibility to consistently
positive results from large recent studies covering lifetime
surgery and pointing to likewise underlying diluting effects.
7 8
In a study with negative results, retina surgery was unfortu-
nately not investigated separately from other ophthalmolog-
ical surgery.
12 Findings for lower-risk procedures at >20 years
Table 3 Associations for surgery by tissue/structure contacted 10e19 years before onset or ID-2
Unexposed* Tissue/structure under study Other surgeryy
Tissue/structure Subject n (%) n (%) OR (95% CI) n (%)
Retina, optic nerve Case 110 (65.9) 2 (1.2) 55 (32.9)
MC 603 (72.2) 1 (0.1) 10.7 (0.91 to 124.9) 231 (27.7)
UMC 1569 (70.5) 6 (0.3) 3.97 (0.83 to 18.9) 649 (29.2)
Peripheral nerves Case 110 (65.9) 4 (2.4) 53 (31.7)
MC 603 (72.2) 5 (0.6) 4.41 (1.17 to 16.6) 227 (27.2)
UMC 1569 (70.5) 16 (0.7) 3.83 (1.24 to 11.8) 639 (28.7)
Lymph nodes Case 110 (65.9) 6 (3.6) 51 (30.5)
MC 603 (72.2) 18 (2.2) 1.87 (0.72 to 4.86) 214 (25.6)
UMC 1569 (70.5) 43 (1.9) 1.82 (0.77 to 4.27) 612 (27.5)
Kidney Case 110 (65.9) 1 (0.6) 56 (33.5)
MC 603 (72.2) 3 (0.4) 1.88 (0.19 to 18.5) 229 (27.4)
UMC 1569 (70.5) 0 (0.0) 655 (29.5)
Blood vessels Case 110 (65.9) 5 (3.0) 52 (31.1)
MC 603 (72.2) 24 (2.9) 1.19 (0.44 to 3.23) 208 (24.9)
UMC 1569 (70.5) 50 (2.2) 1.40 (0.55 to 3.58) 605 (27.2)
Anterior ophthalmic Case 110 (65.9) 3 (1.8) 54 (32.3)
MC 603 (72.2) 6 (0.7) 2.74 (0.67 to 11.2) 226 (27.1)
UMC 1569 (70.5) 15 (0.7) 2.57 (0.70 to 9.42) 640 (28.8)
Skeletal muscle Case 110 (65.9) 34 (20.4) 23 (13.8)
MC 603 (72.2) 122 (14.6) 1.58 (1.01 to 2.48) 110 (13.2)
UMC 1569 (70.5) 385 (17.3) 1.41 (0.92 to 2.15) 270 (12.1)
Peritoneum Case 110 (65.9) 19 (11.4) 38 (22.8)
MC 603 (72.2) 67 (8.0) 1.62 (0.91 to 2.89) 165 (19.8)
UMC 1569 (70.5) 190 (8.5) 1.65 (0.97 to 2.79) 465 (20.9)
Subcutaneous Case 110 (65.9) 4 (2.4) 53 (31.7)
MC 603 (72.2) 13 (1.6) 1.73 (0.50 to 5.96) 219 (26.2)
UMC 1569 (70.5) 35 (1.6) 1.64 (0.57 to 4.70) 620 (27.9)
Other tissues Case 110 (65.9) 22 (13.2) 35 (21.0)
MC 603 (72.2) 101 (12.1) 1.22 (0.72 to 2.06) 131 (15.7)
UMC 1569 (70.5) 286 (12.9) 1.20 (0.74 to 1.96) 369 (16.6)
OR for comparisons with unmatched controls (UMC) was adjusted by age, sex and country.
*Reference category. No registered surgery.
yReclassiﬁed procedures involving tissues/structures different from that on study only, shown for clarity.
MC, matched controls.
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tion for main surgical procedures.
9 However, the association
with coronary surgery seen in TW-3 when using unmatched
controls as well as the body system approach does not have
a corresponding ﬁnding here. Since the association of coronary
surgery with sCJD has been reported for Alzheimer’sd i s e a s e
at a similar latency, confounding from vascular risk factors
generating both dementia and coronary disease followed by
coronary surgery may be proposed as a potential explanation
unrelated to prion transmission consistent with absence of
ﬁndings after reclassiﬁcation.
36
Unrecorded information potentially determining our results
might be the length of the pathway to the brain, short in the
case of retina and acoustic nerve. An overlooked autologous dura
mater graft, implanted during the above-mentioned acoustic
neurinoma intervention, was excluded by direct perusal of the
surgeon’s report, issued in 1977, by an author, HL, who excluded
an accidentally transmitted CJD by dura mater implant.
Improved cleaning of instruments in recent times may in part
explain decreased excess risk with shorter latencies.
Blood transfusion has not been identiﬁed as a risk factor
for sCJD; however, Riggs et al warn about the weaknesses of
caseecontrol studies frequently reporting protective effects.
37
Inability to adjust for blood transfusion is a limitation of the
study, since it has been estimated that blood transfusion is
present in 50% of all major surgical interventions
38; blood thus
comprises a potential confounder.
39 Since it would appear that
the excess risk seen here for some tissues, for instance for retina
surgery, is difﬁcult to attribute to simultaneous blood trans-
fusion, some of the present results might be consistent with
confounded effects of surgical instruments and blood. This view
contradicts observations on variant CJD, where transmission by
blood has been demonstrated,
40e43 but not risk excess for
surgery.
44 However, differences between sCJD and vCJD or Kuru
are so large that inferences should perhaps be inappropriate.
Furthermore, the exposures studied might not be independent
phenomena representing either a potential entry site for prions
or the above-mentioned uncontrolled confounding. For example,
cohorting of surgical instruments occurs, and an instrument
used once for retina surgery, for example, has in all likelihood
been repeatedly used for retina surgery. It is therefore possible
that our ﬁndings could in part be explained by infectivity
determined by tissue remnants adhered to instruments (not
controlled for here) rather than by the putative entry site (ie,
tissue contacted). Consequently, the 18%
9 to 35%
7 proportion of
sCJD which has been suggested might be causally related to
surgery, while in theory consistent with observations from
animal models, would be difﬁcult to ascribe to a single biological
mechanism based on these data.
The results might be surprising, since identiﬁed iatrogenic
events related to surgery appear to be very rare. Surveillance
since 1993 by 11 countries at the EUROCJD consortium
includes data on more than 6000 sCJD cases (http://www.
eurocjd.ed.ac.uk/genetic.htm). The number of iatrogenic cases
related to surgery are 53 assigned to dura mater, two to corneal
implants and nil to neurosurgery. However, routine surveillance
data will usually not recognise surgical risk exposures for iatro-
genic CJD other than grafts. Reasons to explain this might be:
(1) the overwhelming difference in annual cohort size, that is
>100000 surgical in-patients per million in Sweden 2004
(http://192.137.163.40/epcfs/index.asp?modul¼ope), versus
approximately 200 dura mater grafts per million in the 1990s in
Table 4 Associations for surgery by tissue/structure contacted, 20 or more years before onset or ID-2
Unexposed* Tissue/structure under study Other surgeryy
Time window Tissue/structure Subject n (%) n (%) OR (95% CI) n (%)
Time window 1 ($20 years) Peripheral nerves Case 134 (80.2) 1 (0.6) 32 (19.2)
MC 745 (89.2) 1 (0.1) 6.27 (0.50 to 78.1) 89 (10.7)
UMC 1985 (89.3) 7 (0.3) 2.12 (0.20 to 21.9) 232 (10.4)
Lymph nodes Case 134 (80.2) 2 (1.2) 31 (18.6)
MC 745 (89.2) 6 (0.7) 2.18 (0.46 to 10.4) 84 (10.1)
UMC 1985 (89.3) 9 (0.4) 2.83 (0.62 to 12.9) 230 (10.3)
Tonsil Case 134 (80.2) 1 (0.6) 32 (19.2)
MC 745 (89.2) 2 (0.2) 3.59 (0.39 to 32.8) 88 (10.5)
UMC 1985 (89.3) 4 (0.2) 6.46 (0.72 to 58.3) 235 (10.6)
Blood vessels Case 134 (80.2) 3 (1.8) 30 (18.0)
MC 745 (89.2) 4 (0.5) 4.54 (1.01 to 20.3) 86 (10.3)
UMC 1985 (89.3) 10 (0.4) 4.15 (1.12 to 15.5) 229 (10.3)
Skeletal muscle Case 134 (80.2) 14 (8.4) 19 (11.4)
MC 745 (89.2) 46 (5.5) 2.04 (1.06 to 3.92) 44 (5.3)
UMC 1985 (89.3) 125 (5.6) 1.87 (1.03 to 3.38) 114 (5.1)
Peritoneum Case 134 (80.2) 11 (6.6) 22 (13.2)
MC 745 (89.2) 32 (3.8) 2.38 (1.14 to 4.96) 58 (6.9)
UMC 1985 (89.3) 66 (3.0) 2.48 (1.26 to 4.88) 173 (7.8)
Subcutaneous Case 134 (80.2) 1 (0.6) 32 (19.2)
MC 745 (89.2) 3 (0.4) 1.98 (0.19 to 20.6) 87 (10.4)
UMC 1985 (89.3) 14 (0.6) 1.06 (0.12 to 9.19) 225 (10.1)
Other tissues Case 134 (80.2) 16 (9.6) 17 (10.2)
MC 745 (89.2) 50 (6.0) 2.26 (1.14 to 4.47) 40 (4.8)
UMC 1985 (89.3) 109 (4.9) 2.24 (1.25 to 4.04) 130 (5.8)
OR for comparisons with unmatched controls (UMC) was adjusted by age, sex and country.
*Reference category. No registered surgery.
yReclassiﬁed procedures involving tissues/structures different from that on study only. Shown for clarity
MC, matched controls.
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45; (2) the comparatively large attrition by low survival of
neurosurgical and dura mater grafted cohorts
45e47; (3) surveil-
lance encompasses the end of the iCJD epidemic
48; (4) large
differences in duration of incubation periods, mean 11 years for
iCJD by dura mater reduce differences in cumulative risk
48; (5)
similar genetic susceptibility might be a strong determinant of
surgical risk linked or not to grafts, and is shared by iCJD and
sCJD as shown by homozygosity at codon 129
48 49 but can be
interpreted in different ways. CJD surveillance captures epide-
miologically compelling evidences required for correct CJD
diagnosis; the OR for exposure to cadaveric dura mater for CDJ
in Japan
50 was 32.5 95% CI (2.6 to inﬁnity). Our three cases
with history of retina surgery were ﬁrst discharged with CJD
diagnosis from three different hospitals, at different years, in
two countries, and most probably diagnosed by different clini-
cians. Views for iCJD from surveillance and results of this study
are perhaps not so difﬁcult to reconcile when biology, diagnosis,
epidemiology and public-health practice
51 are simultaneously
considered.
The potential applicability of results in prevention is complex.
Cautiousness might be recommended for planning of surgical
interventions for patients where CJD diagnosis has been
considered, and for decontamination and quarantining of such
surgical instruments, avoiding reuse during the interval CJD
diagnosis has not been excluded. Established instrument-quar-
antining, -tracking, -cleaning and prion-disinfection policies,
which generally target infrequent procedures, such as neuro-
surgery and ophthalmological, spine and ear surgery,
38 52 are
based on decontamination of remnants and applied to surgical
activity deﬁned by the type of surgeon, that is, by body-system
group. Current sterilisation procedures undertaken in hospitals
for delicate instrumentation are insufﬁcient to ensure total
removal of infectious prion protein, and carriers of infective
prions are difﬁcult to detect.
52 53 Extension of such measures,
after appropriate assessment, to instruments contacting or
potentially contacting veins, female genital organs, peritoneal
cavity, peripheral nerves and muscle could be a priority. In
addition, new decontamination procedures
54 may have a wider-
than-expected ﬁeld of application.
To sum up, these results suggest that surgery constitutes
a risk factor for sCJD, acting with long incubation periods, and
less frequently with shorter latencies when the central- or
peripheral nervous system as well as skeletal muscle are impli-
cated. In addition, results are in concordance with animal
models of experimental prion transmission through various
routes of inoculation that may mimic accidentally transmitted
CJD, and might have implications for prevention of CJD spread
in medical settings.
Acknowledgements EUROSURGYCJD group members. Danish team:
G Falkenhorst, H Laursen, K Mølbak. Finnish team: J Kovanen. Swedish team:
M Cruz, A ˚ Siden. Spanish team: J Almaza ´n, MJ Bleda, M Calero, I Mahillo,
P Martı ´nez-Martı ´n, J de Pedro-Cuesta (coordinator), A Ra ´bano. The
EUROSURGYCJD group members are grateful: to M Pocchiari, Italy, for contributing
to this proposal in respect of the biological plausibility of surgical transmission of
prion disorders; to P Sanchez-Juan, Spain, for criticism; and to M Lo ¨fdahl (Swedish
CJD Surveillance Unit), C-L Spetz, L Forsberg (Socialstyrelsen) and L Caderius
(Population Statistics), Sweden, for their help with data collection.
Funding Funding was obtained from The Research Commission EU, Concerted Action
QLRG3-CT-2002-81223, NEUROPRION, and the Spanish RECSP C03-09, CIEN C03-06
and CIBERNED networks.
Competing interests None.
Ethics approval Ethics approval was provided by the Danish Data Protection Agency
(record No 2003-41-3104) and Karolinska Institute Ethics Committee (South; report
No 452/02).
T
a
b
l
e
5
C
o
m
p
l
e
m
e
n
t
a
r
y
a
n
a
l
y
s
e
s
b
y
r
i
s
k
l
e
v
e
l
P
u
t
a
t
i
v
e
r
i
s
k
c
a
t
e
g
o
r
i
e
s
a
f
t
e
r
r
e
c
l
a
s
s
i
ﬁ
c
a
t
i
o
n
U
n
e
x
p
o
s
e
d
*
H
i
g
h
r
i
s
k
L
o
w
e
r
r
i
s
k
L
o
w
e
s
t
r
i
s
k
N
o
r
i
s
k
o
r
n
o
t
r
e
c
l
a
s
s
i
ﬁ
e
d
T
i
m
e
w
i
n
d
o
w
S
u
b
j
e
c
t
n
(
%
)
n
(
%
)
O
R
(
9
5
%
C
I
)
n
(
%
)
O
R
(
9
5
%
C
I
)
n
(
%
)
O
R
(
9
5
%
C
I
)
n
(
%
)
O
R
(
9
5
%
C
I
)
T
i
m
e
w
i
n
d
o
w
1
(
$
1
5
y
e
a
r
s
)
C
a
s
e
s
1
1
4
(
6
8
.
3
)
0
(
0
.
0
)
4
7
(
2
8
.
1
)
5
(
3
.
0
)
1
(
0
.
6
)
M
C
6
4
2
(
7
6
.
9
)
2
(
0
.
2
)
e
1
3
2
(
1
5
.
8
)
2
.
1
3
(
1
.
3
9
t
o
3
.
2
5
)
5
2
(
6
.
2
)
0
.
5
9
(
0
.
2
2
t
o
1
.
5
5
)
7
(
0
.
8
)
0
.
8
4
(
0
.
1
0
t
o
6
.
7
2
)
U
M
C
1
7
0
3
(
7
6
.
6
)
6
(
0
.
3
)
e
3
7
8
(
1
7
.
0
)
2
.
0
5
(
1
.
4
2
t
o
2
.
9
6
)
1
1
7
(
5
.
3
)
0
.
6
7
(
0
.
2
6
t
o
1
.
7
2
)
2
0
(
0
.
9
)
0
.
8
0
(
0
.
1
0
t
o
6
.
6
2
)
T
i
m
e
w
i
n
d
o
w
2
(
5
e
1
4
y
e
a
r
s
)
C
a
s
e
s
1
1
7
(
7
0
.
1
)
3
(
1
.
8
)
3
4
(
2
0
.
4
)
7
(
4
.
2
)
6
(
3
.
6
)
M
C
5
7
1
(
6
8
.
4
)
8
(
1
.
0
)
1
.
8
5
(
0
.
4
9
t
o
6
.
9
6
)
1
8
8
(
2
2
.
5
)
0
.
8
8
(
0
.
5
9
t
o
1
.
3
3
)
4
8
(
5
.
7
)
0
.
7
1
(
0
.
3
1
t
o
1
.
6
1
)
2
0
(
2
.
4
)
1
.
4
7
(
0
.
5
7
t
o
3
.
7
9
)
U
M
C
1
5
1
2
(
6
8
.
0
)
1
1
(
0
.
5
)
3
.
4
3
(
1
.
0
1
t
o
1
1
.
6
)
5
3
1
(
2
3
.
9
)
0
.
8
3
(
0
.
5
6
t
o
1
.
2
4
)
1
2
3
(
5
.
5
)
0
.
7
6
(
0
.
3
4
t
o
1
.
6
8
)
4
7
(
2
.
1
)
1
.
5
7
(
0
.
6
4
t
o
3
.
8
5
)
T
i
m
e
w
i
n
d
o
w
3
(
1
e
4
y
e
a
r
s
)
C
a
s
e
s
1
3
6
(
8
1
.
4
)
1
(
0
.
6
)
2
2
(
1
3
.
2
)
7
(
4
.
2
)
1
(
0
.
6
)
M
C
6
9
2
(
8
2
.
9
)
3
(
0
.
4
)
1
.
6
8
(
0
.
1
7
t
o
1
6
.
3
)
1
0
4
(
1
2
.
5
)
1
.
0
7
(
0
.
6
6
t
o
1
.
7
6
)
2
1
(
2
.
5
)
1
.
7
0
(
0
.
7
2
t
o
4
.
0
1
)
1
5
(
1
.
8
)
0
.
3
2
(
0
.
0
5
t
o
1
.
8
4
)
U
M
C
1
8
3
1
(
8
2
.
3
)
1
2
(
0
.
5
)
0
.
8
9
(
0
.
1
2
t
o
6
.
6
7
)
2
8
1
(
1
2
.
6
)
0
.
8
9
(
0
.
5
5
t
o
1
.
4
3
)
5
9
(
2
.
7
)
1
.
4
6
(
0
.
6
5
t
o
3
.
2
6
)
4
1
(
1
.
8
)
0
.
2
9
(
0
.
0
4
t
o
2
.
0
7
)
O
R
f
o
r
c
o
m
p
a
r
i
s
o
n
s
w
i
t
h
u
n
m
a
t
c
h
e
d
c
o
n
t
r
o
l
s
(
U
M
C
)
w
a
s
a
d
j
u
s
t
e
d
b
y
a
g
e
,
s
e
x
a
n
d
c
o
u
n
t
r
y
.
*
R
e
f
e
r
e
n
c
e
c
a
t
e
g
o
r
y
.
N
o
r
e
g
i
s
t
e
r
e
d
s
u
r
g
e
r
y
.
M
C
,
m
a
t
c
h
e
d
c
o
n
t
r
o
l
s
.
J Neurol Neurosurg Psychiatry 2011;82:204e212. doi:10.1136/jnnp.2009.188425 211
Research paperContributors JdP-C has full access to all of the data in the study and takes
responsibility for the integrity of the data and the accuracy of the data analysis.
Preliminary results were presented at the EUROCJD/NEUROCJD Public Health EU
Meeting, held in Paris on 5 December 2006.
Provenance and peer review Not commissioned; externally peer reviewed.
REFERENCES
1. Kondo K, Kuroiwa Y. A caseecontrol study of CreutzfeldteJakob disease:
association with physical injuries. Ann Neurol 1982;11:377e81.
2. Davanipour Z, Alter M, Sobel E, et al. CreutzfeldteJakob disease: possible medical
risk factors. Neurology 1985;35:1483e6.
3. Harries-Jones R, Knight RSG, Will RG, et al. CreutzfeldteJakob disease in England
and Wales, 1980e1984: a caseecontrol study of potential risk factors. J Neurol
Neurosurg Psychiatry 1988;51:1113e19.
4. van Duijn CM, Delasnerie-Laupre ˆtre N, Masullo C, et al. Caseecontrol study of risk
factors of CreutzfeldteJakob disease in Europe during 1993e95. Lancet
1998;351:1081e5.
5. Zerr I, Brandel J-P, Masullo C, et al. European surveillance on CreutzfeldteJakob
disease: a caseecontrol study for medical risk factors. J Clin Epidemiol
2000;53:747e54.
6. Collins S, Law MG, Fletcher A, et al. Surgical treatment and risk of sporadic
CreutzfeldteJakob disease: a caseecontrol study. Lancet 1999;353:69.
7. Ward HJT, Everington D, Croes EA, et al. Sporadic CreutzfeldteJakob disease and
surgery: a caseecontrol study using community controls. Neurology
2002;59:543e8.
8. Ward HJ, Everington D, Cousens SN, et al. Risk factors for sporadic
CreutzfeldteJakob disease. Ann Neurol 2008;63:347e54.
9. Mahillo-Fernandez I, de Pedro-Cuesta J, Bleda MJ, et al. Surgery and risk of
sporadic CreutzfeldteJakob disease in Denmark and Sweden: registry-based
caseecontrol studies. Neuroepidemiology 2008;31:229e40.
10. Riegger J, Stoeck K, Amsler L, et al. A caseecontrol study of sporadic
CreutzfeldteJakob disease in Switzerland: analysis of potential risk factors with
regard to an increased CJD incidence in the years 2001-2004. BMC Public Health
2009;9:18.
11. Hamaguchi T, Noguchi-Sinohara E, Nozaki I, et al. Medical procedures and risk for
sporadic CreutzfeldteJakob disease, Japan, 1999-2008. Emerg Infect Dis
2009;15:265e71.
12. S-Juan P, Ward HJ, De Silva R, et al. Ophthalmic surgery and CreutzfeldteJakob
disease. Br J Ophthalmol 2004;88:446e9.
13. Wientjens DPWM, Davanipour Z, Hofman A, et al. Risk factors for
CreutzfeldteJakob disease: a reanalysis of caseecontrol studies. Neurology
1996;46:1287e91.
14. Barash JA, Johnson BT, Gregorio I. Is surgery a risk factor for CreutzfeldteJakob
disease? Outcome variation by control choice and exposure assessments. Infect
Control Hosp Epidemiol 2008;29:212e18.
15. Ward H, Knight R. Surgery and risk of sporadic CreutzfeldteJakob disease.
Neuroepidemiology 2008;31:241e2.
16. CJD UK Incidents Panel. Management of possible exposure to CJD through
medical procedures: a consultation paper. London: Department of Health
Publications, 2001:11e27.
17. de Pedro-Cuesta J, Bleda MJ, Ra ´bano A, et al. Classiﬁcation of surgical procedures
for epidemiologic assessment of sporadic CreutzfeldteJakob disease transmission by
surgery. Eur J Epidemiology 2006;21:595e604.
18. Zerr I, Pocchiari M, Collins S, et al. Analysis of EEG and CSF 14-3-3 proteins as aids
to the diagnosis of CreutzfeldteJakob disease. Neurology 2000;55:811e15.
19. Klassiﬁkation av operationer, 6:e upplagan. Socialstyrelsen. Norstedts T.
Stockholm, 1993.
20. Operations og Behandlings-Klassiﬁkation, 3 udgave. Sundhedsstyrelsen,
Copenhagen. Munksgaard, 1988.
21. Nordic Medico Statistical Committee N. NOMESCO classiﬁcation of surgical
procedures. Copenhagen: NOTEX, 2003.
22. Ra ´bano A, de Pedro-Cuesta J, Mølbak K, et al. Tissue classiﬁcation for the
epidemiologic assessment of surgical transmission of sporadic CreutzfeldteJakob
disease. A proposal on hypothetical risk levels. BMC Public Health 2005;5:9.
23. Rothman KJ, Greenland S, Last TL. Modern epidemiology. 3rd edn. Philadelphia, PA:
Lippincott Williams & Wilkins, 2008:234e7.
24. Dosemeci M, Wacholder S, Lubin JH. Does non-differenctial misclassiﬁcation of
exposure always bias a true effect toward the null value? Am J Epidemiol
1990;132:746e8.
25. Health Technology and Pharmaceuticals Cluster W. WHO guidelines on
transmissible spongiform encephalopathies I relation to biological and pharmaceutical
products. WHO/BCT/QSD/03.01,1e26 2003.
26. Kimberlin RH, Walker CA. Pathogenesis of scrapie (strain 263K) in hamsters
infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol
1986;67:255e63.
27. Race R, Oldstone M, Chesebro B. Entry versus blockade of brain infection following
oral or intraperitoneal scrapie administration: role of prion protein expression in
peripheral nerves and spleen. J Virol 2000;74:828e33.
28. Bradley R. Animal prion diseases. in prion diseases. In: Collinge J, Palmer MS, eds.
Oxford: Oxford University Press, 1997.
29. Scott JR, Foster JD, Fraser H. Conjunctival instillation of scrapie in mice can produce
disease. Vet Microbiol 1993;34:305e9.
30. Fraser H. Neuronal spread of scrapie agent and targeting of lesions within the
retino-tectal pathway. Nature 1982;295:149e50.
31. Brandner S, et al. Normal host prion protein (PrPC) is required for scrapie spread
within the CNS. Proc Natl Acad Sci USA 1996;93:13148e51.
32. Beekes M, McBride PA, Baldauf E. Cerebral targeting indicates vagal spread of
infection in hamsters fed with scrapie. J Gen Virol 1998;79:601e7.
33. Aguzzi A, Calella M. Prions: Protein aggregation and infectious diseases. Physiol Rev
2009;89:1105e52.
34. Bartz JC, Dejoia C, Tucker T, et al. Extraneural prion neuroinvasion without
lymphoreticular system infection. J Virol 2005;79:11858e63.
35. Kimberlin RH, Hall SM, Walker CA. Pathogenesis of mouse scrapie. Evidence for
direct neural spread of infection to the CNS after injection of sciatic nerve. J Neurol
Sci 1983;61:315e25.
36. Knopman DS, Petersen RC, Cha RH, et al. Coronary artery bypass grafting is not
a risk factor for dementia or Alzheimer disease. Neurology 2005;65:986e90.
37. Riggs JE, Moudgil SS, Hobbs GR. CreutzfeldteJakob disease and blood
transfusions: a meta-analysis of caseecontrol studies. Mil Med 2001;166:1057e8.
38. Garske T, Ward HT, Clarke P, et al. Factors determining the potential for onward
transmission of variant CreutzfeldteJakob disease via surgical instruments. J R Dsoc
Interface 2006;3:757e66.
39. Brown P. CreutzfeldteJakob disease: reﬂections on the risk from blood product
therapy. Haemophillia 2007;13(Suppl 5):33e40.
40. Llewelyn CA, Hewitt PE, Knight RS, et al. Possible transmission of variant
CreutzfeldteJakob disease by blood transfusion. Lancet 2004;363:417e21.
41. Peden AH, Head MW, Ritchie DL, et al. Preclinical vCJD after blood transfusion in
a codon 129 heterozygous patient. Lancet 2004;364:527e9.
42. Collinge J. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry
2005;76:906e19.
43. Wroe SJ, Pal S, Siddique D, et al. Clinical presentation and pre-mortem diagnosis of
variant CreutzfeldteJakob disease associated with blood transfusion: a case report.
Lancet 2006;368:2061e7.
44. Ward HJ, Everington D, Cousens SN, et al. Risk factors for variant
CreutzfeldteJakob disease: a caseecontrol study. Ann Neurol 2006;59:111e20.
45. Nakamura Y, Aso E, Yanagawa H. Relative risk of CreutzfeldteJakob disease with
cadaveric dura transplantation in Japan. Neurology 1999;53:218e20.
46. Martinez-Lage JF, Poza M, Brown P, et al. Enfermedad de CreutzfeldteJakob en
Neurocirugia: una revisio ´n de riesgos y medidas de prevencio ´n. Neurocirugia
1997:8:284e93.
47. Bird SM, Merrall EL, Ward HJ, et al. Survival and re-operation rates after
neurosurgical procedures in Scotland: implications for targeted surveillance of
sub-clinical variant CreutzfeldteJakob disease. Neuroepidemiology 2009;33:1e11.
48. Brown P, Brandel JP, Preese M, et al. Iatrogenic CreutzfeldteJakob disease. The
waning of an era. Neurology 2006;67:389e93.
49. Kova ´cs GG, Puopolo M, Ladogana A, et al. Genetic prion disease: the EUROCJD
experience. Hum Genet 2005;118:166e74.
50. Nakamura Y, Oki I, Tanihara S, et al. A caseecontrol study of CreutzfeldteJakob
disease in Japan: transplantation of cadaveric dura mater was a risk factor.
J Epidemiol 2000;10:399e402.
51. Lenglet A, Herna ´ndez Pezzi G. Comparison of the European Union Disease
Surveillance Networks’ websites. Euro Surveill 2006;11:ii625.
52. Yan Z, Stitz L, Heeg P, et al. Infectivity of prion protein bound to stainless steel wires:
a model for testing decontamination procedures for transmissible spongiform
encephalopathies. Infect Control Hosp Epidemiol 2004;25:280e3.
53. Baxter RL, Baxter HC, Campbell GA, et al. Quantitative analysis of residual protein
contamination on reprocessed surgical instruments. J Hosp Infect 2006;63:439e44.
54. Lemmer K, Mielke M, Kratzel C, et al. Decontamination of surgical instruments from
prions. II. In vivo ﬁndings with a model system for testing the removal of scrapie
infectivity from steel surfaces. J Gen Virol 2008;89:348e58.
212 J Neurol Neurosurg Psychiatry 2011;82:204e212. doi:10.1136/jnnp.2009.188425
Research paper